Kyverna Therapeutics, Inc. (KYTX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 351K | 0 | 0 | 515K | 501K | 563K | 29.19M | 0 | 22.48K | 17.16M | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -351K | 0 | 0 | -515K | -501K | -563K | -29.19M | 0 | -22.48K | -17.16M | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 29.94% | 100% | 100% | - | -2129.04% | 96.72% | - | - | - | - | - | - |
| Operating Expenses | 41.02M | 39.28M | 38.73M | 43.9M | 46.91M | 40.48M | 9.58M | 33.44M | 6.88K | 4.21M | 16.28M | 13.3M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 11.29M | 9.27M | 8.27M | 8.59M | 9.97M | 7.56M | 7.88M | 6.11M | 5.78K | 4.21M | 2.64M | 2.9M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 29.72M | 30.01M | 30.46M | 35.82M | 37.43M | 32.92M | 29.19M | 27.32M | 22.48K | 17.16M | 13.64M | 10.4M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | -515K | -501K | 0 | -1000K | 0 | -21.38K | -1000K | 0 | 0 |
| Operating Income | -41.37M | -39.28M | -38.73M | -44.41M | -47.41M | -41.04M | -38.77M | -33.44M | -29.36K | -21.38M | -16.28M | -13.3M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 12.74% | 4.29% | 0.11% | -32.82% | -161382.39% | -91.99% | -138.12% | -151.35% | - | - | - | - |
| EBITDA | -41.02M | -38.91M | -38.31M | -43.9M | -46.91M | -40.48M | -38.45M | -32.91M | -29.11K | -21.15M | -15.84M | -12.89M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 12.56% | 3.86% | 0.36% | -33.4% | -161020.46% | -91.42% | -142.67% | -155.3% | - | - | - | - |
| D&A (Non-Cash Add-back) | 351K | 368K | 415K | 515K | 501K | 563K | 321K | 530K | 245 | 231K | 438K | 413K |
| EBIT | -41.37M | -37.36M | -36.78M | -42.07M | -44.61M | -37.46M | -37.07M | -28.76M | -28.26K | -21.38M | -15.41M | -13.04M |
| Net Interest Income | 1.66M | 1.46M | 1.99M | 2.35M | 2.8M | 3.55M | 4.32M | 4.66M | 2.69M | 742K | 830K | 218K |
| Interest Income | 2.33M | 1.91M | 2M | 2.36M | 2.83M | 3.58M | 4.36M | 4.69M | 2.73M | 789K | 880K | 264K |
| Interest Expense | 667K | 444K | 7K | 14K | 25K | 27K | 32K | 39K | 44K | 47K | 50K | 46K |
| Other Income/Expense | 1.64M | 1.48M | 1.94M | 2.33M | 2.77M | 3.55M | 4.28M | 4.63M | 2.67K | 710K | 817K | 211K |
| Pretax Income | -39.73M | -37.8M | -36.79M | -42.08M | -44.63M | -37.49M | -34.49M | -28.8M | -26.69K | -20.67M | -15.46M | -13.09M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -39.73M | -37.8M | -36.79M | -42.08M | -44.63M | -37.49M | -34.49M | -28.8M | -26.69K | -20.67M | -15.46M | -13.09M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 10.99% | -0.84% | -6.65% | -46.1% | -167116.12% | -81.4% | -123.03% | -120.02% | - | - | - | - |
| Net Income (Continuing) | -39.73M | -37.8M | -36.79M | -42.08M | -44.63M | -37.49M | -34.49M | -28.8M | -26.69K | -20.67M | -15.46M | -13.09M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.66 | -0.80 | -0.85 | -0.97 | -1.03 | -0.87 | -0.80 | -0.67 | -1.12 | -0.48 | -0.36 | -0.30 |
| EPS Growth % | 35.92% | 8.05% | -6.25% | -44.78% | 8.04% | -81.25% | -122.22% | -123.33% | - | - | - | - |
| EPS (Basic) | -0.66 | -0.80 | -0.85 | -0.97 | -1.03 | -0.87 | -0.80 | -0.67 | -1.12 | -0.48 | -0.36 | -0.30 |
| Diluted Shares Outstanding | 60.43M | 47.16M | 43.42M | 43.23M | 43.22M | 43.21M | 43.16M | 43.13M | 23.75M | 43.12M | 43.12M | 43.12M |
| Basic Shares Outstanding | 60.43M | 47.16M | 43.42M | 43.23M | 43.22M | 43.21M | 43.16M | 43.13M | 23.75M | 43.12M | 43.12M | 43.12M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |